From Potential ‘Bloodbath’ To Promo Warnings: Semaglutide’s India Reckoning

 
• By Anju Ghangurde
  
obesity
Indian regulator cautions pharma on GLP-1 RA ads ahead of semaglutide LOE (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from India

More from Scrip